# Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children

> **NCT01772056** · PHASE3 · TERMINATED · sponsor: **Elena Rubio Gomis** · enrollment: 54 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** Fluticasone, cream
- **DRUG:** Placebo,

## Key facts

- **NCT ID:** NCT01772056
- **Lead sponsor:** Elena Rubio Gomis
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2012-01
- **Final completion:** 2013-03
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** Patient recruitment is very slow, economic grant has ended and the number of patients is enough according to sample size (22 children/ arm).
- **Last updated:** 2015-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772056, "Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01772056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*